Vaping as good as Chantix to help quit smoking, study finds

The JAMA study is the first published randomized controlled trial to compare varenicline, also known as Chantix, directly to e-cigarettes.

June 17, 2024 Check out STAT+

Sponsored By

JOEL SAGET/AFP via Getty Images Vaping is just as good as Chantix at helping people quit cigarettes, new study finds E-cigarettes were nearly as effective at helping people quit smoking as the gold-standard pharmaceutical drug varenicline, JAMA study says. By Nicholas Florko STAT+ | Oncologists turn to blood test for circulating tumor DNA, but questions remain on how to use the data The tests for ctDNA are seen as good indicator of whether cancer will return after surgery. But they don't always clarify the next step. By Angus Chen STAT+ | Under pressure to thwart pharma patent abuse, the PTO proposes a new rule. But will it fly? "In one fell swoop, it can make a difference, and would address patent thickets," explained Sean Tu, a law professor at West Virginia University. By Ed Silverman Alex Brandon/AP Inside Anthony Fauci's 'On Call': 9 health and science takeaways from the memoir of America's most famous doctor To read the forthcoming memoir, "On Call: A Doctor's Journey in Public Service," is to get a sense of Fauci's finesse while advising seven presidents. By Jason Mast Bird flu snapshot: A critic of the U.S. response speaks out, and USDA tries to 'corner the virus' As of Friday, the USDA had confirmed infections in 102 herds in 12 states, while Iowa said it had found two more that haven't yet made it to the USDA list. By Helen Branswell STAT+ | Why a big California employer ditched Elevance for some of its health plans The deal could be a model for other large employers that want insurers to keep prices in check and steer people toward high-quality doctors. By Bob Herman Adobe Opinion: I'm a hypochondriac. Here's how the health care system needs to deal with people like me A professed hypochondriac — and high-ranking health care executive — sees way to improve care while eliminating unnecessary tests and costs. By Hal Rosenbluth

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser